Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Mar 31, 2018

Filed with the SEC on May 16, 2018 and accepted by EDGAR at May 16, 2018, 01:15 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2018-01-01 to 2018-03-31$105.0kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2018-01-01 to 2018-03-31−$1.1mus-gaap:OperatingIncomeLoss
Net income3 months2018-01-01 to 2018-03-31−$1.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-01-01 to 2018-03-31−$0.17us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2018-01-01 to 2018-03-31−$591.3kus-gaap:NetCashProvidedByUsedInOperatingActivities
Current assetsAt period end2018-03-31$32.3kus-gaap:AssetsCurrent
Total assetsAt period end2018-03-31$243.8kus-gaap:Assets
Current liabilitiesAt period end2018-03-31$5.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-03-31$6.6mus-gaap:Liabilities
Short-term borrowingsAt period end2018-03-31$369.1kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2018-03-31−$6.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-18-006399. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.